Expert Analysis of the California $5,000,000 Business Credit Limitation and its Critical Impact on Research and Development Tax Incentives (Tax Years 2024-2026)

The Credit Limitation of $5,000,000 mandates the maximum dollar amount by which all accrued California business tax credits, including the R&D Credit and any related carryovers, can reduce the taxpayer’s net tax liability in any single year. This restriction is effective only for tax years beginning on or after January 1, 2024, and before January 1, 2027.

Section 1: The Statutory and Regulatory Framework of the Limitation

1.1. Detailed Analysis of the Limitation’s Scope and Function

The temporary $5,000,000 limitation (the “Credit Limitation”) on the utilization of California business tax credits represents a significant, though temporary, constraint on corporate tax planning, particularly for entities benefiting from the California Research Credit (R&TC Section 23609). This measure was enacted as part of a legislative package designed to stabilize state revenues during a period of fiscal adjustment.1

The limitation applies comprehensively, affecting the application of all business credits, including those generated in the current taxable year and those carried over from prior taxable years.2 The critical mechanism of the statute is that the total reduction in “net tax” (for personal income filers) or “tax” (for corporate filers) attributable to the utilization of these business credits cannot exceed the $5 million threshold.2 This is an annual cap, resetting each taxable year within the effective period.

1.2. Legislative Context, Duration, and Revenue and Taxation Code Basis

The statutory foundation for the Credit Limitation is derived primarily from Senate Bill (SB) 167 and Senate Bill (SB) 175, both signed into law in June 2024.1 These bills established new sections within the Revenue and Taxation Code (R&TC), specifically Sections 17039.4 and 23036.4, which govern the application of the cap for Personal Income Tax and Corporation Tax purposes, respectively.

The effective period of the limitation is strictly defined by the legislation. It applies to taxable years beginning on or after January 1, 2024, and before January 1, 2027.2 Taxpayers are therefore required to apply this limitation for the 2024, 2025, and 2026 tax years. The temporary nature of this measure, confirmed by the sunset provision at the end of 2026, provides a degree of certainty for long-term tax provision planning, allowing taxpayers to anticipate the full utilization of deferred credits starting in the 2027 taxable year.

The policy rationale for this fiscal intervention is further evidenced by its coordination with other revenue-generating measures enacted in the same period. SB 167 simultaneously suspended the ability of taxpayers with net business income exceeding $1 million to utilize their California Net Operating Losses (NOLs) for the same 2024-2026 period.1 The coordinated suspension of both NOL utilization and tax credit application demonstrates a clear legislative focus on increasing near-term cash tax receipts from high-income businesses. This structure suggests that policymakers view the Research Credit itself as a valuable, long-term incentive, but one that is temporarily constrained for immediate fiscal purposes, necessitating a strategic focus on maximizing carryovers that will become fully available when the restrictions lift.

1.3. Scope of Affected Credits and Statutory Exclusions

The breadth of the Credit Limitation requires taxpayers to aggregate all business tax credits generated by the entity or group, including the R&D Tax Credit. The limitation explicitly encompasses the application of credits, including carryover amounts, generated under various statutes.2

The Franchise Tax Board (FTB) instructions clarify that certain credits are statutorily exempt from the $5 million utilization cap:

1. Low-Income Housing Credit: This credit is explicitly excluded from the $5,000,000 limitation.5
2. Credit for Prior Year Alternative Minimum Tax (AMT): This credit is also not subject to the Credit Limitation.5

The distinction between included and excluded credits is significant for compliance. The exclusion of the Low-Income Housing Credit (a social policy credit intended to stimulate housing development) and the AMT Credit (a mechanism for recovering historical tax payments) indicates a prioritization of these specific statutory goals over the immediate revenue goal addressed by the Credit Limitation.5 For compliance purposes, these excluded credits are applied against the tax liability first, effectively reducing the net tax base upon which the $5 million limitation for all other business credits (including R&D) is calculated.

Section 2: Detailed Application Mechanics and FTB Guidance

2.1. Initial Calculation of the California R&D Credit (FTB 3523)

The Research Credit is quantified using Form FTB 3523, “Research Credit”.2 The calculation must occur before the $5 million utilization cap is applied. California’s Research Credit calculation mirrors the federal structure (IRC Section 41) but with critical state-specific modifications, particularly concerning rates and geographic scope.6

The standard calculation rate is the sum of:

• 15% of qualified research expenses (QREs) exceeding a statutory base amount.6
• 24% of basic research payments.6

Alternatively, taxpayers may elect the Alternative Incremental Credit (AIRC) method on a timely filed original return.2 Under the AIRC method, reduced, three-tiered credit rates apply (1.49%, 1.98%, and 2.48%) to specified increments of QREs that exceed corresponding fixed-base percentages.8 Regardless of the calculation method chosen, the research activities must have been conducted within California to qualify for the state credit.2 Once the total credit is calculated, this figure is aggregated with all other business credits and carryovers before applying the $5 million utilization cap.

2.2. The Aggregation Rule: Application at the Combined Reporting Group Level

For large multi-state or multi-entity businesses filing a single unitary tax return, the application of the Credit Limitation is particularly restrictive. FTB guidance explicitly confirms that for taxpayers included in a combined report, the $5,000,000 limitation is applied at the group level.1

This aggregation rule means that if a combined reporting group generates $20 million in eligible credits across all its member entities, the group’s aggregate tax reduction from those credits is still capped at $5 million. The remaining $15 million in accrued credit value is designated as disallowed credit, subject to carryover or the refundability election.

The group-level application introduces a layer of complexity regarding internal allocation. A unitary group must establish a documented method for distributing the $5 million benefit among the tax liabilities of the various members in the combined report. Effective tax provision modeling requires a rigorous process to prioritize which entities receive the credit benefit up to the $5 million threshold, often favoring entities with the greatest immediate cash tax liability or those holding credits with shorter statutory carryforward periods (though the R&D credit itself carries over indefinitely in California).10

Furthermore, the assignment of credits under R&TC Section 23663 is also constrained by this rule. If a credit generator assigns an eligible credit (such as the R&D credit) to an eligible assignee, the assignee must include the claimed assigned credit in its calculation of business credits subject to the group’s overall $5 million limit.5

2.3. Credit Ordering Rules and the Definition of Disallowed Credits

The sequencing of credit utilization is critical because only the credit that is disallowed due to the $5 million statutory cap is eligible for the special refundability election provided by SB 175.

The process of credit application generally follows these steps, as dictated by R&TC Section 23036(c) and FTB instructions:

1. Non-Carryover Credits: Credits that cannot be carried over are utilized first.11
2. Carryover Credits (R&D): Credits that contain carryover provisions but are not allowed to reduce net tax below the tentative minimum tax (TMT) are applied next.11 The R&D credit falls into this category.
3. AMT Credit and Other Specific Credits: The AMT credit is applied, followed by credits that may reduce tax below the TMT.11
4. The $5M Cap Application: After determining the maximum amount of credit that could be utilized based on the tax liability (TML) and standard ordering rules, the aggregate total utilization of business credits must be limited to $5,000,000.

The determination of the “disallowed” credit amount eligible for the refundable election is subject to a strict interpretation by the FTB. Credits that are limited by the tax liability—meaning the credit exceeded the calculated tax before the $5 million cap was applied—are not eligible for the refundable election.2 These amounts remain standard carryovers subject to the normal rules.

R&TC Section 17039.5 specifies that the “credit amount” eligible for refundability is only the amount of qualified credits that would have otherwise been available to reduce net tax in the taxable year but for the limitation under Section 17039.4 (the $5M cap).13 This distinction is essential to ensure that taxpayers do not convert economically non-utilizable credits (due to low tax basis) into a future cash refund stream.

Section 3: Management of Disallowed Credits: Carryover vs. Refundability

When a taxpayer’s potential credit utilization exceeds the $5,000,000 annual limit, the excess must be managed through one of two mechanisms established by the legislation: standard carryover or the irrevocable refundable credit election.

3.1. Default Treatment: Extended Carryover Mechanism

If the taxpayer chooses not to elect refundability, the disallowed business credits automatically become carryovers.2 The California R&D credit inherently contains an indefinite carryover provision.6

A significant protective feature of SB 167 is the extension of the carryover period for all credits impacted by the limitation. The carryover period is extended by the number of taxable years the credit utilization was not allowed due to the $5 million cap.5 Since the limitation spans three years (2024, 2025, 2026), the carryforward period for any affected credit with a defined expiration date is effectively extended by three years.1 For the R&D credit, which already has an indefinite carryforward, this extension primarily ensures the credit’s value is preserved until the cap terminates.

3.2. The Irrevocable Election for Refundable Credit (Form FTB 3870)

SB 175 provided a mechanism that allows taxpayers to elect to receive an annual cash refund for credits disallowed due to the $5 million limitation.1 This choice converts a deferred tax asset (the carryover credit) into a future cash receivable, altering the timing and nature of the tax benefit.

• Election Procedures: This choice is characterized as an irrevocable election that must be made annually for each taxable year the limitation is in effect.2 The election is formalized by completing the new Form FTB 3870, Election for Refundable Credit, and submitting it with the original, timely filed tax return.2
• Payout Structure: The refundable credit amount is paid out over a five-year period, with the taxpayer claiming 20% of the total disallowed amount annually.2
• Delayed Payout Commencement: The critical detail of the refundability election is the delayed start date: the five-year refundable period begins the third taxable year after the taxable year in which the election is made.2 For a credit disallowed in the 2024 tax year, the first 20% refund payment would not be received until the 2027 tax year.

The decision between carryover and refundability hinges on a rigorous Net Present Value (NPV) analysis. The delayed commencement and multi-year payment schedule of the refundable election significantly discounts the real value of the credit due to the time value of money, particularly if the entity has a high cost of capital. Conversely, if the taxpayer projects low tax profitability beginning in 2027, the refundable election provides guaranteed cash realization regardless of future tax liability, offering balance sheet certainty.

3.3. Specific Rules for S Corporations and Credit Assignments

• S Corporations: Special rules apply to pass-through entities. While S corporations can pass 100% of the R&D credit through to their shareholders on a pro-rata basis, the entity itself is prohibited from electing to make entity-level credits refundable.2 The $5 million limitation and the refundability election determination are applied at the individual shareholder level (for the credit passed through).
• Consistency Mandate: If a taxpayer elects to make a credit, such as the R&D credit, refundable due to the $5 million limitation, they must make the same election for all other credits claimed in that year that were also disallowed due to the limitation.2 This prevents selective credit management, forcing a comprehensive strategy for the disallowed credit pool.

Section 4: Addressing Contextual Misconceptions and Legal Precedent

4.1. Distinction from the Federal Qualified Small Business Gross Receipts Test

A source of confusion in R&D tax planning is the existence of a separate $5,000,000 threshold related to the federal R&D tax credit. It is essential to delineate the context of the California utilization cap from this federal eligibility test.

The federal rule, stemming from the PATH Act of 2015, allows a Qualified Small Business (QSB) to elect to offset up to $500,000 of the federal R&D credit against payroll taxes.16 To qualify as a QSB, a firm must meet two tests, one of which is having less than $5,000,000 in annual gross receipts for the tax year.16

The critical distinction is summarized in the table below: the federal $5 million relates to gross receipts (an income measure) used for eligibility for a specific federal benefit (payroll tax offset), whereas the California $5 million relates to the utilization of the state credit (a reduction measure) applied against tax liability.2 The two thresholds are unrelated in their application, purpose, and statutory authority.

Table: Comparison of $5M Thresholds in R&D Tax Planning

4.2. Linkage to NOL Suspension and Historical Context

The current Credit Limitation (2024-2026) is not without precedent. California previously implemented a similar $5,000,000 cap on business credit utilization for tax years beginning on or after January 1, 2020, and before January 1, 2023, under Assembly Bill (AB) 85.18

The recurrence of the $5 million cap, coupled with the coordinated suspension of NOL utilization during the same three-year period (2024-2026), confirms that these are synchronized, temporary fiscal policy tools employed by the state to maximize short-term general fund revenue.1 The history of similar caps and the specific sunset date of the current limitation structure allow taxpayers to confidently budget for the full release of accumulated deferred tax benefits starting in the 2027 tax year, assuming no further legislative intervention extends the period.

Section 5: Detailed Quantitative Example and Strategic Implications

To illustrate the financial impact and strategic decisions required by the $5,000,000 limitation, an analysis of a hypothetical large corporate entity is necessary.

5.1. Case Study: Unitary Combined Reporting Group (Group A)

Assume Group A, a technology enterprise, files a combined report in California.

• Taxable Year: January 1, 2024 – December 31, 2024.
• Taxable Income (CA Apportioned): $400,000,000
• Corporate Tax Rate (Assumed 8.84%):
• Tentative Minimum Tax Liability (TML): $35,360,000

Group A’s Total Available Tax Credits for 2024:

5.2. Analysis of Limitation Application

1. Application of Excluded Credits: The LIHC is utilized first, as it is exempt from the $5M cap.5
   $$\text{Tax Liability after LIHC} = \$35,360,000 – \$500,000 = \$34,860,000$$
2. Total Credits Subject to Cap: The total pool of R&D and CCTC credits is $\$7,500,000 + \$3,000,000 = \$10,500,000$.
3. Application of the $5M Utilization Cap: The $10,500,000 in eligible business credits cannot reduce the remaining tax liability by more than $\$5,000,000$.

• Allowed Utilization (Maximum): $5,000,000.
• Final Tax Due: $34,860,000 – $5,000,000 = $29,860,000.

1. Determination of Disallowed Credit:
   
   $$\text{Disallowed Credit} = \$10,500,000 – \$5,000,000 = \mathbf{\$5,500,000}$$

In this scenario, the entire $\$5,500,000$ excess is the amount disallowed but for the limitation itself, assuming the tax liability ($34.86M) was sufficient to absorb the full $\$10.5$ million had the cap not been in place. Therefore, the $\$5,500,000$ is eligible for either carryover or the refundability election.

5.3. Strategic Decision: Managing the Disallowed Credit Pool

Group A must now make a definitive choice regarding the $\$5,500,000$ disallowed credit. This choice requires a forward-looking assessment of the economic value under both options.

Option 1: Default Carryover

If Group A elects carryover, the $\$5,500,000$ is added to the general credit carryforward balance, to be utilized against tax liability fully starting in 2027. Because the California R&D credit already carries forward indefinitely, this option prioritizes high tax offsets in the year the cap expires. This path is financially advantageous if the group has strong confidence in sustained high CA taxable income post-2026. This preserves the full nominal value of the credits for immediate 2027 tax reduction.

Option 2: Irrevocable Refund Election (FTB 3870)

If Group A elects refundability (using Form FTB 3870), the $\$5,500,000$ is converted into a structured receivable:

• Annual Refund Amount: $\$5,500,000 \times 20\% = \$1,100,000$
• First Payment Year (2024 Election): 2027 (third taxable year after election)
• Total Payout Period: 2027 through 2031

The crucial consideration here is liquidity versus tax optimization. While the carryover (Option 1) provides a large, immediate offset against the 2027 tax liability, the refund election (Option 2) guarantees cash flow even if Group A’s profitability declines after the 2026 sunset date. Tax planning teams must perform a discounted cash flow analysis, applying the internal cost of capital to the stream of payments under Option 2, and comparing the resulting NPV to the NPV of the tax shield provided by Option 1 in 2027 and beyond.

For financial reporting purposes (ASC 740), the $\$ 5,500,000$ is a Deferred Tax Asset (DTA) regardless of the choice. However, the refundable election stream, characterized as a future cash receivable, necessitates careful assessment of realizability and potential valuation allowances, particularly given the highly deferred nature of the cash flow, commencing three years after the election.2

Section 6: Conclusion and Forward-Looking Recommendations

The California $5,000,000$ Credit Limitation, imposed via SB 167 and SB 175 for tax years 2024 through 2026, constitutes a substantial, temporary restriction on the immediate utility of the Research and Development Tax Credit and other business incentives. While the legislation constrains near-term cash tax savings, it preserves the long-term value of accrued R&D credits through robust carryover and refundability mechanisms.

6.1. Essential Compliance and Documentation Mandates

Compliance requires absolute precision, particularly concerning credit ordering and the refundability election:

1. Prioritization of Excluded Credits: Taxpayers must apply excluded credits (Low-Income Housing, AMT) first, prior to calculating the utilization of other business credits against the $5 million cap.
2. Accurate Definition of Disallowed Credit: It is mandatory to isolate the portion of the credit disallowed specifically by the $5 million limitation (R&TC Section 17039.4), excluding any portion limited merely by insufficient tax basis. Only the former is eligible for conversion to a refundable credit.
3. Timely and Irrevocable Election: Should a taxpayer elect refundability, the annual, irrevocable election must be documented meticulously using the new Form FTB 3870 and filed concurrently with the original, timely filed tax return for the year the credit was disallowed.2 A failure to meet this timing requirement forfeits the refund option permanently for that taxable year.
4. Combined Group Allocation: Unitary groups must formalize and document the methodology for allocating the allowable $5 million utilization cap across member entities to ensure internal consistency and compliance with the group-level restriction.1

6.2. Strategic Planning Directives

The legislative structure—suspending utilization while extending the carryover period and providing a deferred cash alternative—protects the economic value of the R&D investment. Consequently, the temporary restriction should not discourage continued investment in California qualified research activities (QREs).

Taxpayers are advised to:

• Model Future Utilization: Conduct rigorous financial modeling forecasting projected tax liability for the post-2026 period. High confidence in significant CA taxable income in 2027 and beyond favors retaining the credit as a carryover, maximizing its future tax shield value.
• Evaluate Cost of Capital: Apply the company’s weighted average cost of capital to the deferred five-year refund stream to accurately determine the Net Present Value (NPV) of the refundable election. This analysis should drive the annual decision on whether to file FTB 3870 or default to the extended carryover.4

Maintain R&D Focus: Recognizing that the California R&D credit carries over indefinitely 10, taxpayers should maintain a strategy of maximizing QREs, treating the resulting credits accrued during the 2024-2026 period as secured, highly valuable deferred tax assets slated for full realization beginning in 2027.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/